文献速递咽喉与嗓音

反常声带运动障碍诊疗的经济负担

Economic Burden Associated With Management of Paradoxical Vocal Fold Motion Disorder.
PubMed 文献 · Laryngoscope · 2021-07-17

该回顾性研究纳入110例反常声带运动障碍(PVFM)患者,评估从呼吸困难起病到确诊的时间及诊断前后直接与间接医疗费用,并比较是否接受言语治疗的费用差异。结果显示确诊中位时间为33个月,诊断前直接费用中位数达8625美元,药物是各时期主要费用驱动因素;完成言语治疗者85%症状改善且费用显著节省。

要点

  • PVFM从呼吸困难起病到确诊中位时间长达33个月,易误诊为哮喘。
  • 诊断前直接医疗费用中位数8625美元,药物是各时期主要费用驱动。
  • 完成言语治疗者85%呼吸症状改善,且较症状持续者显著节省费用。

核心结论

  • PVFM确诊前的诊疗费用相当高,需更高效识别患者以缩短确诊时间并降低相关费用。

研究设计与样本

  • 回顾性研究,纳入110例确诊为PVFM的患者,测量呼吸困难起病至确诊时间,计算诊断前后直接与间接费用,并比较言语治疗与否及疗效成功与否的费用。

主要发现

  • 110例患者从呼吸困难起病到PVFM确诊的中位时间为33个月(IQR 5-60)。
  • 诊断前直接费用中位数8625美元(IQR 1687-35812),间接费用中位数736美元(IQR 421-1579)。
  • 呼吸困难起病后第一年直接费用中位数1706美元(IQR 427-7118),间接费用中位数315美元(IQR 131-631)。
  • 诊断后一年直接费用中位数2062美元(IQR 760-11496),间接费用中位数841美元(IQR 631-1261)。
  • 药物在所有时期均为主要费用驱动因素;完成言语治疗者85%呼吸症状改善,且较症状持续者显著节省费用。

临床怎么用

  • 对长期呼吸困难且哮喘治疗反应不佳者应警惕PVFM,尽早识别以缩短确诊延迟。
  • 言语治疗可改善多数完成者的呼吸症状并可能降低后续费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Paradoxical vocal fold movement (PVFM) is often misdiagnosed as asthma and tends to have a prolonged time to diagnosis. Study aims were to estimate the time from dyspnea onset to PVFM diagnosis, to estimate associated pre- and postdiagnosis direct and indirect healthcare cost, and to compare the cost of postdiagnosis care among patients who did and did not undergo standard-of-care speech therapy. METHODS: Patients diagnosed with PVFM were identified retrospectively. Time from dyspnea symptom onset to diagnosis was measured. Direct costs consisting of office visits, procedures, and prescribed pharmaceuticals before and after diagnosis were calculated. Indirect costs associated with lost wages related to healthcare were also estimated. Costs for patients who initiated versus did not initiate speech therapy and who had successful versus unsuccessful therapy were compared. RESULTS: Among 110 patients, median time from dyspnea onset to PVFM diagnosis was 33 months (interquartile range [IQR] 5-60). Direct and indirect prediagnosis median costs were $8,625 (IQR $1,687-$35,812) and $736 (IQR $421-$1,579) while first year following dyspnea symptom onset median direct and indirect costs were $1,706 (IQR $427-$7,118) and $315 (IQR $131-$631). Median direct and indirect costs of care in the postdiagnosis year were $2,062 (IQR $760-$11,496) and $841 (IQR $631-$1,261). Pharmaceuticals were predominant cost drivers in all time periods. Of those who completed speech therapy, 85% had breathing symptom improvement while incurring significant cost savings compared to those whose symptoms persisted. CONCLUSION: Costs of care leading to diagnosis of PVFM are substantial. More efficient methods of identifying patients with PVFM are essential to reduce prolonged time to diagnosis and associated costs. LEVEL OF EVIDENCE: NA Laryngoscope, 132:142-147, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lunga T, Thibeault SL, Francis DO, et al. Economic Burden Associated With Management of Paradoxical Vocal Fold Motion Disorder. Laryngoscope. 2021. PMID: 34272886. doi:10.1002/lary.29754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。